Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients-Reference-Cited by-同舟云学术

Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients

Published:2004-09 Issue:5 Volume:24 Page:495-501
ISSN:0270-9295
Container-title:Seminars in Nephrology
language:en
Short-container-title:Seminars in Nephrology

Author:

Molino Daniela,De Santo Natale G.,Marotta Rosa,Anastasio Pietro,Mosavat Mahrokh,De Lucia Domenico

Publisher

Elsevier BV

Subject

Nephrology

Reference25 articles.

1. Bleeding time in uremia;Steiner;Am J Hematol,1979

2. Coagulation abnormalities in uremia;Livio;Semin Nephrol,1985

3. Bleeding in renal failure;Remuzzi;Lancet,1988

4. Uremic bleeding;Noris;Blood,1999

5. Haemodialysis and platelet activation;Deguchi;Nephrol Dial Transplant,1991

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature;Antibodies;2024-01-02

2. A Molecular Troika of Angiogenesis, Coagulopathy and Endothelial Dysfunction in the Pathology of Avascular Necrosis of Femoral Head: A Comprehensive Review;Cells;2023-09-14

3. Navigating through the haemostatic paradox in kidney failure: A practical overview;British Journal of Haematology;2023-06-04

4. Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment;International Journal of Molecular Sciences;2020-11-10

5. Antiphospholipid antibodies in end‐stage renal disease: A systematic review and meta‐analysis;Hemodialysis International;2020-06-10